Rajesh A. Maheshwari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rajesh A. Maheshwari has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Dhanya B. Sen
Department of Pharmacy Sumandeep Vidyapeeth Deemed to be University Vadodara Gujarat India
7 shared publications - Ashim Kumar Sen
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara-391760, Gujarat, India
6 shared publications - Ramachandran Balaraman
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Vadodara – 391760, Gujarat
6 shared publications - Ghanshyam Parmar
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Piparia, Waghodia, Vadodara-391760, Gujarat, India
4 shared publications - Nirmal Shah
Department of Pharmacy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, India
4 shared publications - Dipti Gohil
Department of Pharmacy Sumandeep Vidyapeeth Deemed to be University Vadodara Gujarat India
3 shared publications
Latest Publications
- 29 October 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (10) , 2701-2708
Ameliorative Effect of Convolvulus pluricaulis in a Rat Model of Ulcerative Colitis
Background: Ulcerative colitis (UC) is a chronic inflammatory disease characterized by recurrent inflammation and ulceration of the colonic mucosa. Its pathogenesis involves immune dysfunction, inflammatory cytokine production, and oxidative stress. Although conventional drugs provide symptomatic relief, prolonged therapy may cause undesirable side effects. Convolvulus pluricaulis possesses anti-inflammatory, antioxidant, and gastroprotective properties; however, its protective effects in experimental UC remain insufficiently investigated. Objective: The present research focused on evaluating the therapeutic potential of the methanol extract of C. pluricaulis (CPE) in a chemically induced model of ulcerative colitis in rats using dextran sulfate sodium. Methods: Ulcerative colitis was induced in Wistar rats by administering 5% DSS in drinking water for 14 days. Animals were divided into six groups: normal control, disease control, three CPE-treated groups (250, 500, and 1000 mg/kg, orally), and a sulfasalazine-treated group (500 mg/kg). Treatments were administered from day 14 to day 56. Evaluation parameters included the Disease Activity Index (DAI), colon length and weight, superoxide dismutase (SOD) and catalase activities, TNF-α, IL-6, and CRP levels, and colonic histopathological changes. Results: The disease control group exhibited increased DAI, colon weight, inflammatory biomarkers, and histological damage, with decreased antioxidant enzyme activities. CPE at 500 and 1000 mg/kg reduced DAI scores, preserved colon length, decreased colon weight, significantly suppressed CRP, TNF-α, and IL-6 levels, and restored SOD and catalase activities. Histological examination revealed substantial protection of colonic tissue architecture at these doses. The 250 mg/kg dose produced minor, statistically insignificant improvements in most parameters. The effects of higher CPE doses were comparable to those of sulfasalazine. Conclusion: Convolvulus pluricaulis extract exhibited dose-dependent anti-inflammatory and antioxidant effects in DSS-induced colitis in rats. Doses of 500 and 1000 mg/kg effectively alleviated biochemical and histopathological indicators of colonic damage, suggesting its potential as a therapeutic candidate for ulcerative colitis. Major Findings: C. pluricaulis methanol extract demonstrated significant dose-dependent amelioration of DSS-induced colitis, particularly at 500 and 1000 mg/kg, by reducing disease activity, inflammatory mediators (TNF-α, IL-6, and CRP), and colonic damage while restoring SOD and catalase activities. Histopathological evaluation corroborated the biochemical findings, indicating preservation of colonic mucosal architecture and attenuation of inflammation.
- 29 October 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (10) , 2701-2708
Ameliorative Effect of Convolvulus pluricaulis in a Rat Model of Ulcerative Colitis
Background: Ulcerative colitis (UC) is a chronic inflammatory disease characterized by recurrent inflammation and ulceration of the colonic mucosa. Its pathogenesis involves immune dysfunction, inflammatory cytokine production, and oxidative stress. Although conventional drugs provide symptomatic relief, prolonged therapy may cause undesirable side effects. Convolvulus pluricaulis possesses anti-inflammatory, antioxidant, and gastroprotective properties; however, its protective effects in experimental UC remain insufficiently investigated. Objective: The present research focused on evaluating the therapeutic potential of the methanol extract of C. pluricaulis (CPE) in a chemically induced model of ulcerative colitis in rats using dextran sulfate sodium. Methods: Ulcerative colitis was induced in Wistar rats by administering 5% DSS in drinking water for 14 days. Animals were divided into six groups: normal control, disease control, three CPE-treated groups (250, 500, and 1000 mg/kg, orally), and a sulfasalazine-treated group (500 mg/kg). Treatments were administered from day 14 to day 56. Evaluation parameters included the Disease Activity Index (DAI), colon length and weight, superoxide dismutase (SOD) and catalase activities, TNF-α, IL-6, and CRP levels, and colonic histopathological changes. Results: The disease control group exhibited increased DAI, colon weight, inflammatory biomarkers, and histological damage, with decreased antioxidant enzyme activities. CPE at 500 and 1000 mg/kg reduced DAI scores, preserved colon length, decreased colon weight, significantly suppressed CRP, TNF-α, and IL-6 levels, and restored SOD and catalase activities. Histological examination revealed substantial protection of colonic tissue architecture at these doses. The 250 mg/kg dose produced minor, statistically insignificant improvements in most parameters. The effects of higher CPE doses were comparable to those of sulfasalazine. Conclusion: Convolvulus pluricaulis extract exhibited dose-dependent anti-inflammatory and antioxidant effects in DSS-induced colitis in rats. Doses of 500 and 1000 mg/kg effectively alleviated biochemical and histopathological indicators of colonic damage, suggesting its potential as a therapeutic candidate for ulcerative colitis. Major Findings: C. pluricaulis methanol extract demonstrated significant dose-dependent amelioration of DSS-induced colitis, particularly at 500 and 1000 mg/kg, by reducing disease activity, inflammatory mediators (TNF-α, IL-6, and CRP), and colonic damage while restoring SOD and catalase activities. Histopathological evaluation corroborated the biochemical findings, indicating preservation of colonic mucosal architecture and attenuation of inflammation.
- 30 September 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (9) , 2235-2249
Benevolent Role of Spices in Management of Metabolic Syndrome
Metabolic syndrome (MetS) represents a multifactorial disorder characterised by insulin resistance, central obesity, dyslipidemia, and hypertension, predisposing individuals to type 2 diabetes mellitus, cardiovascular disease, and related chronic conditions. Conventional pharmacotherapy often targets individual components of MetS, but may be limited by side effects, partial efficacy, and poor long-term adherence. Dietary interventions, particularly the use of spices rich in bioactive phytochemicals, offer a promising complementary strategy for managing MetS through multi-targeted mechanisms. Culinary spices such as cinnamon, turmeric, ginger, garlic, black pepper, fenugreek, cardamom, coriander, clove, curry leaf, chia seed, Panax ginseng, and black seed exhibit hypoglycemic, hypolipidemic, antihypertensive, antioxidant, and anti-inflammatory properties. Such bioactive constituents modulate key metabolic pathways, including insulin signalling, glucose uptake, lipid metabolism, adipokine regulation, and oxidative stress mitigation. Clinical and preclinical evidence supports their efficacy in improving glycemic control, lipid profile, blood pressure, endothelial function, and inflammatory status, thereby reducing cardiometabolic risk. Major Finding: Collectively, the integration of such spices into dietary regimens represents a safe, cost-effective, and comprehensive approach for the anticipation and management of metabolic syndrome.
- 30 September 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (9) , 2235-2249
Benevolent Role of Spices in Management of Metabolic Syndrome
Metabolic syndrome (MetS) represents a multifactorial disorder characterised by insulin resistance, central obesity, dyslipidemia, and hypertension, predisposing individuals to type 2 diabetes mellitus, cardiovascular disease, and related chronic conditions. Conventional pharmacotherapy often targets individual components of MetS, but may be limited by side effects, partial efficacy, and poor long-term adherence. Dietary interventions, particularly the use of spices rich in bioactive phytochemicals, offer a promising complementary strategy for managing MetS through multi-targeted mechanisms. Culinary spices such as cinnamon, turmeric, ginger, garlic, black pepper, fenugreek, cardamom, coriander, clove, curry leaf, chia seed, Panax ginseng, and black seed exhibit hypoglycemic, hypolipidemic, antihypertensive, antioxidant, and anti-inflammatory properties. Such bioactive constituents modulate key metabolic pathways, including insulin signalling, glucose uptake, lipid metabolism, adipokine regulation, and oxidative stress mitigation. Clinical and preclinical evidence supports their efficacy in improving glycemic control, lipid profile, blood pressure, endothelial function, and inflammatory status, thereby reducing cardiometabolic risk. Major Finding: Collectively, the integration of such spices into dietary regimens represents a safe, cost-effective, and comprehensive approach for the anticipation and management of metabolic syndrome.
- 28 September 2026
- Published by Wiley in Molecular Informatics
- Vol. 45 (10) , e70055
Property‐Conditioned Transformer Language Model for De Novo Molecular Generation Using Self‐Referencing Embedded Strings
Transformer‐based molecular language models have demonstrated strong capabilities for de novo molecular generation by modeling chemical structures as token sequences. However, controllable generation of molecules with desired physicochemical properties remains challenging without reinforcement learning (RL) or post‐generation filtering. In this study, we propose a property‐conditioned autoregressive transformer framework for molecular generation using the SELFIES representation. Continuous molecular descriptors, including logP, quantitative estimate of drug‐likeness, and molecular weight (MolWt), were normalized and embedded via a multilayer perceptron and injected into token embeddings to enable global conditioning during sequence modeling. The model was trained end‐to‐end using the maximum likelihood with cross‐entropy loss. Experiments conducted on the combined subsets of QM9, ZINC, and MOSES datasets demonstrated high validity (100%), strong uniqueness, and substantial novelty in the generated molecules. Furthermore, the generated property distributions closely aligned with the training data statistics. The proposed framework provides a computationally efficient and stable approach for controllable molecular generation without requiring RL or graph‐based modeling.
- 28 September 2026
- Published by Wiley in Molecular Informatics
- Vol. 45 (10) , e70055
Property‐Conditioned Transformer Language Model for De Novo Molecular Generation Using Self‐Referencing Embedded Strings
Transformer‐based molecular language models have demonstrated strong capabilities for de novo molecular generation by modeling chemical structures as token sequences. However, controllable generation of molecules with desired physicochemical properties remains challenging without reinforcement learning (RL) or post‐generation filtering. In this study, we propose a property‐conditioned autoregressive transformer framework for molecular generation using the SELFIES representation. Continuous molecular descriptors, including logP, quantitative estimate of drug‐likeness, and molecular weight (MolWt), were normalized and embedded via a multilayer perceptron and injected into token embeddings to enable global conditioning during sequence modeling. The model was trained end‐to‐end using the maximum likelihood with cross‐entropy loss. Experiments conducted on the combined subsets of QM9, ZINC, and MOSES datasets demonstrated high validity (100%), strong uniqueness, and substantial novelty in the generated molecules. Furthermore, the generated property distributions closely aligned with the training data statistics. The proposed framework provides a computationally efficient and stable approach for controllable molecular generation without requiring RL or graph‐based modeling.
- Open Access
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 911-917
Herbal Therapies for Asthma: A Review of Traditional and Modern Perspectives
This review explores the potential of nine herbal plants - Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng in preventing and alleviating asthma symptoms. Asthma, a chronic inflammatory airway disease, often benefits from conventional treatments, but interest in natural alternatives is growing. Traditional herbal medicines show promise as alternative treatments and management strategies for asthma. Research highlights that many of these herbs exhibit anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory effects, which are crucial for addressing asthma’s underlying mechanisms. For instance, compounds like curcumin from Turmeric and thymoquinone from Black Seed have demonstrated anti-inflammatory and bronchodilatory properties. Ginger and Holy Basil have shown immunomodulatory effects that can help control airway inflammation. While current evidence often stems from in vitro, animal, or preliminary human studies, suggesting a role in symptomatic relief and potentially inhibiting disease progression, further rigorous clinical trials are needed to confirm their preventive efficacy and establish clear guidelines for their use as natural alternatives to conventional drugs, ultimately aiming to improve the quality of life for asthmatic patients. Major Finding: The review concludes that Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng show strong potential in alleviating asthma and evidence from laboratory, animal, and limited human studies indicates they may improve airway function and reduce inflammation with therapeutic efficacy in asthma management.
- 25 April 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 911-917
Open AccessHerbal Therapies for Asthma: A Review of Traditional and Modern Perspectives
This review explores the potential of nine herbal plants - Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng in preventing and alleviating asthma symptoms. Asthma, a chronic inflammatory airway disease, often benefits from conventional treatments, but interest in natural alternatives is growing. Traditional herbal medicines show promise as alternative treatments and management strategies for asthma. Research highlights that many of these herbs exhibit anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory effects, which are crucial for addressing asthma’s underlying mechanisms. For instance, compounds like curcumin from Turmeric and thymoquinone from Black Seed have demonstrated anti-inflammatory and bronchodilatory properties. Ginger and Holy Basil have shown immunomodulatory effects that can help control airway inflammation. While current evidence often stems from in vitro, animal, or preliminary human studies, suggesting a role in symptomatic relief and potentially inhibiting disease progression, further rigorous clinical trials are needed to confirm their preventive efficacy and establish clear guidelines for their use as natural alternatives to conventional drugs, ultimately aiming to improve the quality of life for asthmatic patients. Major Finding: The review concludes that Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng show strong potential in alleviating asthma and evidence from laboratory, animal, and limited human studies indicates they may improve airway function and reduce inflammation with therapeutic efficacy in asthma management.
- 31 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (1) , 1177-1195
A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway
The present investigation aims to establish the mechanism of curcumin in targeting diabetes and obesity, specifically through its effects on Adipoq, Il-6, and Tnf-α, using network pharmacology-based in silico analysis, followed by in silico validation. Target genes associated with diabetes and obesity were identified using GeneCards and SwissTargetPrediction, revealing that curcumin modulates Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway, suggesting a novel therapeutic mechanism. In this study, the effects of curcumin on diabetic rats were evaluated by assessing blood sugar levels (BSL), HbA1c, insulin levels, and adipocytokine expression. Diabetes was induced, and rats were treated with curcumin or pioglitazone for 4 weeks, followed by biochemical analysis. The in silico experimental findings demonstrate that curcumin is more effective than pioglitazone in managing obesity-induced diabetes by modulating the mRNA expression of adipocytokines. These results align with the predictions from in silico analysis, supporting the hypothesis that curcumin targets Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway. This study introduces a targeted approach for diabetes management by modulating adipocytokines with curcumin. The integration of in silico analysis with in silico validation provides a comprehensive framework for developing novel therapeutic strategies against obesity-induced diabetes. Graphical abstract
- 31 July 2025
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (1) , 1177-1195
A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway
The present investigation aims to establish the mechanism of curcumin in targeting diabetes and obesity, specifically through its effects on Adipoq, Il-6, and Tnf-α, using network pharmacology-based in silico analysis, followed by in silico validation. Target genes associated with diabetes and obesity were identified using GeneCards and SwissTargetPrediction, revealing that curcumin modulates Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway, suggesting a novel therapeutic mechanism. In this study, the effects of curcumin on diabetic rats were evaluated by assessing blood sugar levels (BSL), HbA1c, insulin levels, and adipocytokine expression. Diabetes was induced, and rats were treated with curcumin or pioglitazone for 4 weeks, followed by biochemical analysis. The in silico experimental findings demonstrate that curcumin is more effective than pioglitazone in managing obesity-induced diabetes by modulating the mRNA expression of adipocytokines. These results align with the predictions from in silico analysis, supporting the hypothesis that curcumin targets Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway. This study introduces a targeted approach for diabetes management by modulating adipocytokines with curcumin. The integration of in silico analysis with in silico validation provides a comprehensive framework for developing novel therapeutic strategies against obesity-induced diabetes. Graphical abstract
- 30 June 2025
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 30 (6) , 863-874
Design and development of leflunomide loaded topical microsponge gel: insights from ex vivo and in vivo inflammatory studies
Leflunomide, a frequently used medicament, falls under the category of disease modifying anti-rheumatoid drugs. The tablets are the only product available in the market which may lead to liver toxicity upon long term use. Being a class II drug, there is a need of some novel formulation for minimizing systemic toxicity of drug without compromising its therapeutic potential. Microsponges possess unique characteristics that makes it a versatile drug delivery carrier. Leflunomide loaded Microsponges were prepared with matrix forming polymer (ethyl cellulose) and stabilizer (poly vinyl alcohol) using quasi emulsion solvent diffusion method. Two independent parameters, namely concentrations of polymer and stabilizing agent, were examined using a full 32 factorial design to determine their impact on particle size and % entrapment efficiency. The optimized formulation showed promising result for particle size (48.96µm) and entrapment efficiency (89.45%) with spherical and tiny pores on surface. The optimized gel exhibited sustained release up to 8 h (91.46 ± 3.84%) with satisfactory results of flux and permeability coefficient. The developed formulation has good anti-inflammatory properties in wistar rats and a histopathology investigation on rats' skin verified its skin compatibility. The stability study showed stable formulation up to the period of three months. These findings demonstrated the potential of microsponges to improve the therapeutic potential of poorly soluble leflunomide.
- 30 June 2025
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 30 (6) , 863-874
Design and development of leflunomide loaded topical microsponge gel: insights from ex vivo and in vivo inflammatory studies
Leflunomide, a frequently used medicament, falls under the category of disease modifying anti-rheumatoid drugs. The tablets are the only product available in the market which may lead to liver toxicity upon long term use. Being a class II drug, there is a need of some novel formulation for minimizing systemic toxicity of drug without compromising its therapeutic potential. Microsponges possess unique characteristics that makes it a versatile drug delivery carrier. Leflunomide loaded Microsponges were prepared with matrix forming polymer (ethyl cellulose) and stabilizer (poly vinyl alcohol) using quasi emulsion solvent diffusion method. Two independent parameters, namely concentrations of polymer and stabilizing agent, were examined using a full 32 factorial design to determine their impact on particle size and % entrapment efficiency. The optimized formulation showed promising result for particle size (48.96µm) and entrapment efficiency (89.45%) with spherical and tiny pores on surface. The optimized gel exhibited sustained release up to 8 h (91.46 ± 3.84%) with satisfactory results of flux and permeability coefficient. The developed formulation has good anti-inflammatory properties in wistar rats and a histopathology investigation on rats' skin verified its skin compatibility. The stability study showed stable formulation up to the period of three months. These findings demonstrated the potential of microsponges to improve the therapeutic potential of poorly soluble leflunomide.
- Open Access
- 1 June 2025
- Published by BRNSS Publication Hub in Asian Journal of Pharmaceutics
- Vol. 19 (2)
The Dual Action of Vitamin D and Atorvastatin in Rebalancing Metabolic Functions and Adipocytokine Expression in Metabolic Syndrome Rats
The Asian Journal of Pharmaceutics is a peer-reviewed open-access medical journal published by Medknow Publications on behalf of the B.R. Nahata Smriti Sansthan (Memorial Trust) (Mandsaur, India). Articles address topics in pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy.
- 1 June 2025
- Published by BRNSS Publication Hub in Asian Journal of Pharmaceutics
- Vol. 19 (2)
Open AccessThe Dual Action of Vitamin D and Atorvastatin in Rebalancing Metabolic Functions and Adipocytokine Expression in Metabolic Syndrome Rats
The Asian Journal of Pharmaceutics is a peer-reviewed open-access medical journal published by Medknow Publications on behalf of the B.R. Nahata Smriti Sansthan (Memorial Trust) (Mandsaur, India). Articles address topics in pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy.
- Open Access
- 7 October 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1923-1934
Role of Natural Polymers in Novel Drug Delivery Systems
Natural polymers have gained significant attention in the field of drug delivery due to their inherent biocompatibility, biodegradability, and low toxicity. This review article aims to provide a comprehensive overview of the diverse roles that natural polymers play in the development of novel drug delivery systems. Beginning with a classification of natural polymers based on their origin (plant, animal, microbial), we explore their unique characteristics and advantages over synthetic counterparts. The review discusses the pivotal role of natural polymers in formulating various drug delivery systems, including sustained/controlled release formulations, targeted delivery platforms, mucoadhesive systems, and nanotechnology-based approaches. Techniques such as emulsification, ionotropic gelation, coacervation, and electrospinning for natural polymer-based drug delivery are elucidated, highlighting their versatility and applicability across different administration routes. Furthermore, we delve into the diverse applications of natural polymers in drug delivery, encompassing oral, transdermal, ocular, injectable, nasal, buccal, and vaginal delivery routes. Recent advances and innovations in combining natural polymers with synthetic counterparts, incorporating stimuli-responsive properties, and personalized medicine approaches are also explored. Despite the numerous advantages offered by natural polymers, challenges such as variability in polymer properties, standardization issues, scale-up challenges, and regulatory considerations are discussed. The review concludes with future perspectives, highlighting emerging trends and opportunities for further research and development in the field of natural polymer-based drug delivery systems. Overall, this review provides valuable insights into the pivotal role of natural polymers in advancing drug delivery technology, paving the way for safer, more efficient, and patient-friendly therapeutic interventions.
- 7 October 2024
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- p. 1923-1934
Open AccessRole of Natural Polymers in Novel Drug Delivery Systems
Natural polymers have gained significant attention in the field of drug delivery due to their inherent biocompatibility, biodegradability, and low toxicity. This review article aims to provide a comprehensive overview of the diverse roles that natural polymers play in the development of novel drug delivery systems. Beginning with a classification of natural polymers based on their origin (plant, animal, microbial), we explore their unique characteristics and advantages over synthetic counterparts. The review discusses the pivotal role of natural polymers in formulating various drug delivery systems, including sustained/controlled release formulations, targeted delivery platforms, mucoadhesive systems, and nanotechnology-based approaches. Techniques such as emulsification, ionotropic gelation, coacervation, and electrospinning for natural polymer-based drug delivery are elucidated, highlighting their versatility and applicability across different administration routes. Furthermore, we delve into the diverse applications of natural polymers in drug delivery, encompassing oral, transdermal, ocular, injectable, nasal, buccal, and vaginal delivery routes. Recent advances and innovations in combining natural polymers with synthetic counterparts, incorporating stimuli-responsive properties, and personalized medicine approaches are also explored. Despite the numerous advantages offered by natural polymers, challenges such as variability in polymer properties, standardization issues, scale-up challenges, and regulatory considerations are discussed. The review concludes with future perspectives, highlighting emerging trends and opportunities for further research and development in the field of natural polymer-based drug delivery systems. Overall, this review provides valuable insights into the pivotal role of natural polymers in advancing drug delivery technology, paving the way for safer, more efficient, and patient-friendly therapeutic interventions.
- 24 June 2024
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 20 (5) , 345-357
Synchronized Assessment of Lobeglitazone Sulfate and Metformin Hydrochloride in Tablet by Robust, High-performance Thin-layer Chromatographic Method
Background: A combination of fixed-doses containing 0.5 mg lobeglitazone sulfate and 500 mg metformin hydrochloride has demonstrated efficacy in enhancing glycemic control in diabetes. Aims: The projected work aimed to establish and validate a high-performance thin-layer chromatographic methodology for the quantification of both drugs in tablet formulations. Objectives: The task involves creating and validating a method in accordance with ICH guidelines to quantify two particular drugs in tablet formulations accurately. Methods: The high-performance thin-layer chromatographic analysis utilized aluminum plates layered with silica gel 60F254, and the solvent system consisted of acetonitrile, 1 M ammonium acetate (methanol), toluene, and triethyl amine (1.5:2.5:4:0.2 v/v/v/v), followed by densitometric scanning at 237 nm. Results: The methodology exhibited linearity in the range of 100-1500 ng/band for lobeglitazone sulfate and 1000-15000 ng/band for metformin hydrochloride, with correlation coefficients of 0.9991 and 0.9992, correspondingly. Exceptional sensitivity was observed, with detection limits of 8.17 ng/band for lobeglitazone sulfate and 271.34 ng/band for metformin hydrochloride, along with quantification limits of 24.75 ng/band for lobeglitazone sulfate and 822.24 ng/band for metformin hydrochloride. The method demonstrated precision (% relative standard deviation of peak area <2) and accuracy (recovery between 96 and 103%). Conclusion: The suggested methodology is fit for the concurrent quantification of both drugs in tablet formulations, making it applicable for routine quality control assessments in laboratories.
- 24 June 2024
- Published by Elsevier in Current Pharmaceutical Analysis
- Vol. 20 (5) , 345-357
Synchronized Assessment of Lobeglitazone Sulfate and Metformin Hydrochloride in Tablet by Robust, High-performance Thin-layer Chromatographic Method
Background: A combination of fixed-doses containing 0.5 mg lobeglitazone sulfate and 500 mg metformin hydrochloride has demonstrated efficacy in enhancing glycemic control in diabetes. Aims: The projected work aimed to establish and validate a high-performance thin-layer chromatographic methodology for the quantification of both drugs in tablet formulations. Objectives: The task involves creating and validating a method in accordance with ICH guidelines to quantify two particular drugs in tablet formulations accurately. Methods: The high-performance thin-layer chromatographic analysis utilized aluminum plates layered with silica gel 60F254, and the solvent system consisted of acetonitrile, 1 M ammonium acetate (methanol), toluene, and triethyl amine (1.5:2.5:4:0.2 v/v/v/v), followed by densitometric scanning at 237 nm. Results: The methodology exhibited linearity in the range of 100-1500 ng/band for lobeglitazone sulfate and 1000-15000 ng/band for metformin hydrochloride, with correlation coefficients of 0.9991 and 0.9992, correspondingly. Exceptional sensitivity was observed, with detection limits of 8.17 ng/band for lobeglitazone sulfate and 271.34 ng/band for metformin hydrochloride, along with quantification limits of 24.75 ng/band for lobeglitazone sulfate and 822.24 ng/band for metformin hydrochloride. The method demonstrated precision (% relative standard deviation of peak area <2) and accuracy (recovery between 96 and 103%). Conclusion: The suggested methodology is fit for the concurrent quantification of both drugs in tablet formulations, making it applicable for routine quality control assessments in laboratories.
- Open Access
- 1 December 2023
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 1 (4) , 175-178
Enhancing drug related problem (DRP) management in Indian healthcare through AI integration: An insight view
- 1 December 2023
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 1 (4) , 175-178
Open AccessEnhancing drug related problem (DRP) management in Indian healthcare through AI integration: An insight view